Search Results

Showing results 9611 - 9620 for 2023?

Diversity Town Hall | Office of Faculty Engagement & Inclusion

...2021 WCM Diversity Week 2019 WCM Diversity Week 2022 WCM Diversity Week 2018 WCM Diversity Week 2023...

https://inclusion.weill.cornell.edu/events/diversity-town-hall-19

Emergency Department and Hospital Utilization Among Older Adults Before and After Identification of Elder Mistreatment. | Rosen Lab

...Publication Type Journal Article Year of Publication 2023 Authors Rosen T, Zhang H, Wen K, Clark S,...

https://rosenlab.weill.cornell.edu/publications/emergency-department-and-hospital-utilization-among-older-adults-and-after

Funding and Equity for University Startups Series: Valuation and Term Sheets | Enterprise Innovation

...12:00pm - Wednesday, February 15, 2023 1:00pm Event Link:  https://us06web.zoom.us/webinar/register/...

https://innovation.weill.cornell.edu/events/funding-and-equity-university-startups-series-valuation-and-term-sheets

Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS) -NRF2- Heme oxygenase-1(HO-1)-NF-кB axis | Pathology & Laboratory Medicine

...menu options Pathology Trainee Research Day - May 22, 2025 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/mitochondrial-grim-19-loss-parietal-cells-promotes-spasmolytic-polypeptide

Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial. | Pathology & Laboratory Medicine

...Publication Type Journal Article Year of Publication 2023 Authors Rubinstein PG, Moore PC, Bimali M...

https://pathology.weill.cornell.edu/research/publications/brentuximab-vedotin-avd-stage-ii-iv-hiv-related-hodgkin-lymphoma-amc-085-phase

Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. | Pathology & Laboratory Medicine

...Publication Type Journal Article Year of Publication 2023 Authors Mastini C, Campisi M, Patrucco E,...

https://pathology.weill.cornell.edu/research/publications/targeting-ccr7-pi3k%CE%B3-overcomes-resistance-tyrosine-kinase-inhibitors-alk

Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma. | Pathology & Laboratory Medicine

...menu options Pathology Trainee Research Day - May 22, 2025 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/lysin-k-specific-demethylase-1-inhibition-enhances-proteasome-inhibitor

Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. | Pathology & Laboratory Medicine

...Publication Type Journal Article Year of Publication 2023 Authors Cheong J-G, Ravishankar A, Sharma...

https://pathology.weill.cornell.edu/research/publications/epigenetic-memory-coronavirus-infection-innate-immune-cells-and-their

Novel genetically engineered mouse models for clear cell renal cell carcinoma. | Pathology & Laboratory Medicine

...Publication Type Journal Article Year of Publication 2023 Authors van der Mijn JC, Laursen KB, Fu L...

https://pathology.weill.cornell.edu/research/publications/novel-genetically-engineered-mouse-models-clear-cell-renal-cell-carcinoma

Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. | Pathology & Laboratory Medicine

...menu options Pathology Trainee Research Day - May 22, 2025 Pathology Trainee Research Day - May 10, 2023...

https://pathology.weill.cornell.edu/research/publications/clinical-utility-whole-genome-dna-methylation-profiling-primary-molecular

Showing results 9611 - 9620 for 2023?